Amedeo Smart

Free Medical Literature Service




  Free Subscription


4 Am J Obstet Gynecol
4 Am J Respir Crit Care Med
1 Antiviral Res
17 BMJ
1 Br J Anaesth
3 Clin Infect Dis
3 Emerg Infect Dis
1 Infect Control Hosp Epidemiol
8 Int J Infect Dis
2 J Infect
15 J Med Virol
7 J Virol
5 Lancet
2 Lancet Infect Dis
2 Life Sci
6 MMWR Morb Mortal Wkly Rep
6 N Engl J Med
8 Nature
1 Radiol Cardiothorac Imaging
8 Science
1 Travel Med Infect Dis

    Am J Obstet Gynecol

  1. ATYEO C, Shook LL, Nziza N, Deriso EA, et al
    COVID-19 booster dose induces robust antibody response in pregnant, lactating, and nonpregnant women.
    Am J Obstet Gynecol. 2022 Jul 19. pii: S0002-9378(22)00562.
    >> Share

  2. KUGELMAN N, Nahshon C, Shaked-Mishan P, Lavie O, et al
    SARS-CoV-2 Immunoglobulin G Antibody Levels in Infants Following Messenger RNA COVID-19 Vaccination During Pregnancy.
    Am J Obstet Gynecol. 2022 Jul 18. pii: S0002-9378(22)00570.
    >> Share

  3. WANG S, Mortazavi J, Hart JE, Hankins JA, et al
    A prospective study of the association between SARS-CoV-2 infection and COVID-19 vaccination with changes in usual menstrual cycle characteristics.
    Am J Obstet Gynecol. 2022 Jul 13. pii: S0002-9378(22)00539.
    >> Share

  4. SUH-BURGMANN EJ, Tierney C, Hung YY, Schmittdiel JA, et al
    Association Between Vaccination Against COVID-19 and Postmenopausal Bleeding.
    Am J Obstet Gynecol. 2022 Jul 11. pii: S0002-9378(22)00543.
    >> Share

    Am J Respir Crit Care Med

  5. KULLBERG RFJ, de Brabander J, Boers LS, Bos LDJ, et al
    Reply to: Microbial Burden-Associated Cytokine Storm May Explain Non-Resolving ARDS in COVID-19 Patients.
    Am J Respir Crit Care Med. 2022 Jul 22. doi: 10.1164/rccm.202207-1346.
    >> Share

  6. YASUMA T, D'Alessandro-Gabazza CN, Kobayashi T, Gabazza EC, et al
    Microbial Burden-Associated Cytokine Storm May Explain Non-Resolving ARDS in COVID-19 Patients.
    Am J Respir Crit Care Med. 2022 Jul 22. doi: 10.1164/rccm.202207-1266.
    >> Share

  7. BODMER J, Levin A, Westoo C, van der Have O, et al
    Intrapulmonary Bronchopulmonary Anastomoses in Severe COVID-19-related Acute Respiratory Failure.
    Am J Respir Crit Care Med. 2022 Jul 20. doi: 10.1164/rccm.202205-0922.
    >> Share

  8. JOFFRE J, Matthay MA, Hellman J
    Reply to: SARS-CoV2 Endotheliopathy: Insights from Single Cell RNAseq.
    Am J Respir Crit Care Med. 2022 Jul 15. doi: 10.1164/rccm.202207-1309.
    >> Share

    Antiviral Res

  9. SAMRAT SK, Xu J, Xie X, Gianti E, et al
    Allosteric inhibitors of the main protease of SARS-CoV-2.
    Antiviral Res. 2022;205:105381.
    >> Share


  10. WISE J
    Covid-19: Infection raises risk of diabetes and heart disease diagnoses in following weeks, study finds.
    BMJ. 2022;378:o1838.
    >> Share

  11. MAHASE E
    Covid-19: Recovery trial set to lose funding as proposal to examine flu drugs is rejected.
    BMJ. 2022;378:o1809.
    >> Share

  12. WILLIAMS S, Michie S
    Covid-19: One year on from "Freedom Day," what have we learnt?
    BMJ. 2022;378:o1803.
    >> Share

  13. Long covid and apheresis: a miracle cure sold on a hypothesis of hope.
    BMJ. 2022;378:o1813.
    >> Share

  14. SAGE I
    A seven point plan to suppress covid infections and reduce disruptions.
    BMJ. 2022;378:o1793.
    >> Share

  15. JONAS A
    Impact of vaping on respiratory health.
    BMJ. 2022;378:e065997.
    >> Share

  16. TANNE JH
    Covid-19: BA.5 variant is now dominant in US as infections rise.
    BMJ. 2022;378:o1770.
    >> Share

  17. HORNE EMF, Hulme WJ, Keogh RH, Palmer TM, et al
    Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records.
    BMJ. 2022;378:e071249.
    >> Share

  18. DYER C
    Covid-19: Up to pound2.7bn of public money at risk from PPE disputes, says watchdog.
    BMJ. 2022;378:o1817.
    >> Share

  19. POPLE D, Monk EJM, Evans S, Foulkes S, et al
    Burden of SARS-CoV-2 infection in healthcare workers during second wave in England and impact of vaccines: prospective multicentre cohort study (SIREN) and mathematical model.
    BMJ. 2022;378:e070379.
    >> Share

    Rapid covid-19 vaccination for health workers.
    BMJ. 2022;378:o1674.
    >> Share

  21. HULME WJ, Williamson EJ, Green ACA, Bhaskaran K, et al
    Comparative effectiveness of ChAdOx1 versus BNT162b2 covid-19 vaccines in health and social care workers in England: cohort study using OpenSAFELY.
    BMJ. 2022;378:e068946.
    >> Share

  22. MCCAY L
    Covid continues to disrupt: what is the plan to deal with it?
    BMJ. 2022;378:o1780.
    >> Share

  23. MCLELLAN A, Abbasi K
    The NHS is not living with covid, it's dying from it.
    BMJ. 2022;378:o1779.
    >> Share

  24. MAHASE E
    Covid-19: High prevalence and lack of hospital beds putting "intense pressure" on ambulances.
    BMJ. 2022;378:o1763.
    >> Share

  25. TANNE JH
    Covid-19: Antimicrobial resistance rose dangerously in US during pandemic, CDC says.
    BMJ. 2022;378:o1755.
    >> Share

  26. DAVIES M
    Long covid patients travel abroad for expensive and experimental "blood washing".
    BMJ. 2022;378:o1671.
    >> Share

    Br J Anaesth

  27. BRADLEY P, Merchant Z, Rowlinson-Groves K, Taylor M, et al
    Feasibility and outcomes of a real-world regional lung cancer prehabilitation programme in the UK.
    Br J Anaesth. 2022 Jul 12. pii: S0007-0912(22)00295.
    >> Share

    Clin Infect Dis

  28. HUYGENS S, Munnink BO, Gharbharan A, Koopmans M, et al
    Sotrovimab resistance and viral persistence after treatment of immunocompromised patients infected with the SARS-CoV-2 Omicron variant.
    Clin Infect Dis. 2022 Jul 22. pii: 6648554. doi: 10.1093.
    >> Share

  29. ROTHBERG MB, Kim P, Shrestha NK, Kojima L, et al
    Protection Against the Omicron Variant Offered by Previous SARS-CoV-2 Infection: A Retrospective Cohort Study.
    Clin Infect Dis. 2022 Jul 22. pii: 6648553. doi: 10.1093.
    >> Share

  30. HATFIELD KM, Baggs J, Wolford H, Fang M, et al
    Effectiveness of COVID-19 vaccination against SARS-CoV-2 Infection among Residents of US Nursing Homes, Before and During the Delta variant Predominance, December 2020 - November 2021.
    Clin Infect Dis. 2022 Jul 20. pii: 6646955. doi: 10.1093.
    >> Share

    Emerg Infect Dis

  31. LOESCHE M, Karlson EW, Talabi O, Zhou G, et al
    Longitudinal SARS-CoV-2 Nucleocapsid Antibody Kinetics, Seroreversion, and Implications for Seroepidemiologic Studies.
    Emerg Infect Dis. 2022;28.
    >> Share

  32. HUBERT CRJ, Acosta N, Waddell BJM, Hasing ME, et al
    Tracking Emergence and Spread of SARS-CoV-2 Omicron Variant in Large and Small Communities by Wastewater Monitoring in Alberta, Canada.
    Emerg Infect Dis. 2022;28.
    >> Share

  33. KAYA D, Falender R, Radniecki T, Geniza M, et al
    Correlation between Clinical and Wastewater SARS-CoV-2 Genomic Surveillance, Oregon, USA.
    Emerg Infect Dis. 2022;28.
    >> Share

    Infect Control Hosp Epidemiol

  34. WANG B, Pineda-Reyes R, Nielsen MC, Baillargeon G, et al
    Single-center investigation on central-line-associated bloodstream infections and blood-culture contamination during the early months of the coronavirus disease 2019 (COVID-19) pandemic.
    Infect Control Hosp Epidemiol. 2022 Jul 20:1-3. doi: 10.1017/ice.2022.
    >> Share

    Int J Infect Dis

  35. ASSAWAKOSRI S, Kanokudom S, Chansaenroj J, Suntronwong N, et al
    Persistence of immunity against Omicron BA.1 and BA.2 following homologous and heterologous COVID-19 booster vaccines in healthy adults after a two-doses AZD1222 vaccination.
    Int J Infect Dis. 2022 Jul 18. pii: S1201-9712(22)00433.
    >> Share

  36. BAIRD D, Muir A, Logan L, MacLennan M, et al
    Validation of the NeuMoDx SARS-CoV-2 Assay with COPAN eNAT(R) and E&O Viral PCR Sample Solution (VPSS) collection media types in comparison with other validated SARS-CoV-2 RNA assays.
    Int J Infect Dis. 2022 Jul 15. pii: S1201-9712(22)00418.
    >> Share

  37. BHATNAGAR T, Chaudhuri S, Ponnaiah M, Yadav PD, et al
    Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B.1.617.2/Delta variant in India, 2021: A multi-centric hospital-based case-control study.
    Int J Infect Dis. 2022 Jul 14. pii: S1201-9712(22)00427.
    >> Share

  38. YIN Q, Li Y, Pan H, Hui T, et al
    Atypical pneumonia caused by Chlamydia Psittaci during the COVID-19 pandemic.
    Int J Infect Dis. 2022 Jul 13. pii: S1201-9712(22)00422.
    >> Share

  39. VOOR IN 'T HOLT AF, Haanappel CP, Rahamat-Langendoen J, Molenkamp R, et al
    Admissions to a large tertiary care hospital and Omicron BA.1 and BA.2 SARS-CoV-2 PCR positivity: primary, contributing, or incidental COVID-19.
    Int J Infect Dis. 2022 Jul 13. pii: S1201-9712(22)00424.
    >> Share

  40. MAAMARI KA, Busaidi IA, Kindi MA, Zadjali F, et al
    Short and long-term immune changes in different severity groups of COVID-19 disease.
    Int J Infect Dis. 2022 Jul 12. pii: S1201-9712(22)00421.
    >> Share

  41. ALOTAIBY M, Krissaane I, Seraihi AA, Alshenaifi J, et al
    SARS-CoV-2 Reinfection Rate and Outcomes in Saudi Arabia: A National Retrospective Study.
    Int J Infect Dis. 2022 Jul 12. pii: S1201-9712(22)00420.
    >> Share

  42. JUANOLA-FALGARONA M, Penarrubia L, Jimenez-Guzman S, Porco R, et al
    Ct values as a diagnostic tool for monitoring SARS-CoV-2 viral load using the QIAstat-Dx(R) Respiratory SARS-CoV-2 Panel.
    Int J Infect Dis. 2022 Jul 12. pii: S1201-9712(22)00419.
    >> Share

    J Infect

  43. HUANG L
    Adjusted control rate closely associated with the epidemiologic evolution of the recent COVID-19 wave in Shanghai, with 94.3% of all new cases being asymptomatic on first diagnosis.
    J Infect. 2022 Jul 14. pii: S0163-4453(22)00418.
    >> Share

  44. HAGIYA H, Hikita T, Habu T, Asada M, et al
    Poor vaccine responsiveness towards third-dose mRNA vaccine of COVID-19 in Japanese older people.
    J Infect. 2022 Jul 11. pii: S0163-4453(22)00413.
    >> Share

    J Med Virol

  45. OSTERDAHL MF, Christakou E, Hart D, Harris F, et al
    Concordance of B and T cell responses to SARS-CoV-2 infection, irrespective of symptoms suggestive of COVID-19.
    J Med Virol. 2022 Jul 21. doi: 10.1002/jmv.28016.
    >> Share

  46. LIANG Y, Gong Z, Guo J, Cheng Q, et al
    Spatiotemporal analysis of the morbidity of global Omicron from November 2021 to February 2022.
    J Med Virol. 2022 Jul 21. doi: 10.1002/jmv.28013.
    >> Share

  47. WANG Y, Wang X, Luu LDW, Li J, et al
    Single-cell transcriptomic atlas reveals distinct immunological responses between COVID-19 vaccine and natural SARS-CoV-2 infection.
    J Med Virol. 2022 Jul 20. doi: 10.1002/jmv.28012.
    >> Share

  48. YANG Y, Zhao R, Wang Y, Song D, et al
    Rapid and universal detection of SARS-CoV-2 and influenza A virus using a reusable dual-channel optic fiber immunosensor.
    J Med Virol. 2022 Jul 20. doi: 10.1002/jmv.28015.
    >> Share

  49. CHEEMA HA, Shahid A, Aziz H
    Severe acute pediatric hepatitis: the undue emphasis on adenovirus needs to be reassessed.
    J Med Virol. 2022 Jul 20. doi: 10.1002/jmv.28014.
    >> Share

  50. DE VITO A, Colpani A, Bitti A, Zauli B, et al
    Safety and efficacy of molnupiravir in SARS-CoV-2 infected patients: a real-life experience.
    J Med Virol. 2022 Jul 20. doi: 10.1002/jmv.28011.
    >> Share

  51. HUANG D, Lin S, He J, Wang Q, et al
    Association between COVID-19 and telomere length: a bidirectional Mendelian randomization study.
    J Med Virol. 2022 Jul 19. doi: 10.1002/jmv.28008.
    >> Share

  52. MONARI C, Pisaturo M, Maggi P, Macera M, et al
    J Med Virol. 2022 Jul 19. doi: 10.1002/jmv.28007.
    >> Share

  53. HUANG N, Wang C, Han B, Zhao T, et al
    Change in willingness to COVID-19 vaccination in China: two online surveys during the pandemic.
    J Med Virol. 2022 Jul 18. doi: 10.1002/jmv.28004.
    >> Share

  54. CHEN J, Liu X, Liu W, Yang C, et al
    Comparison of the respiratory tract microbiome in hospitalized COVID-19 patients with different disease severity.
    J Med Virol. 2022 Jul 15. doi: 10.1002/jmv.28002.
    >> Share

  55. JASIM SA, Mahdi RS, Bokov DO, Najm MAA, et al
    The deciphering of the immune cells and marker signature in COVID-19 pathogenesis: An update.
    J Med Virol. 2022 Jul 14. doi: 10.1002/jmv.28000.
    >> Share

  56. VAIRA LA, De Riu G, Boscolo-Rizzo P, Hopkins C, et al
    In response to: Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: The ANOSVID study.
    J Med Virol. 2022 Jul 13. doi: 10.1002/jmv.27999.
    >> Share

  57. FERRAVANTE C, Arslan-Gatz BS, Dell'Annunziata F, Palumbo D, et al
    Dynamics of nasopharyngeal tract phageome and association with disease severity and age of patients during three waves of COVID-19.
    J Med Virol. 2022 Jul 13. doi: 10.1002/jmv.27998.
    >> Share

  58. FILHO FFD, Chaves EBM, D'Avila KG, Neyeloff JL, et al
    Clinical characteristics and outcomes of healthcare workers with COVID-19 pre- and postvaccination.
    J Med Virol. 2022 Jul 13. doi: 10.1002/jmv.27997.
    >> Share

  59. RAHMATI M, Keshvari M, Mirnasuri S, Yon DK, et al
    The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: A systematic review and meta-analysis.
    J Med Virol. 2022 Jul 13. doi: 10.1002/jmv.27996.
    >> Share

    J Virol

  60. MOYO-GWETE T, Madzivhandila M, Mkhize NN, Kgagudi P, et al
    Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants.
    J Virol. 2022 Jul 13:e0055822. doi: 10.1128/jvi.00558.
    >> Share

  61. PUSNIK J, Konig J, Mai K, Richter E, et al
    Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response.
    J Virol. 2022 Jul 12:e0076022. doi: 10.1128/jvi.00760.
    >> Share

  62. AICHER SM, Streicher F, Chazal M, Planas D, et al
    Species-Specific Molecular Barriers to SARS-CoV-2 Replication in Bat Cells.
    J Virol. 2022 Jul 5:e0060822. doi: 10.1128/jvi.00608.
    >> Share

  63. CHAPARIAN RR, Harding AT, Hamele CE, Riebe K, et al
    A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice.
    J Virol. 2022 Jul 12:e0068922. doi: 10.1128/jvi.00689.
    >> Share

  64. OISHI K, Horiuchi S, Minkoff JM, tenOever BR, et al
    The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection.
    J Virol. 2022 Jul 12:e0076522. doi: 10.1128/jvi.00765.
    >> Share

  65. XING N, Wang Z, Wang J, Nascimento M, et al
    Engineering and Characterization of Avian Coronavirus Mutants Expressing Fluorescent Reporter Proteins from the Replicase Gene.
    J Virol. 2022 Jul 5:e0065322. doi: 10.1128/jvi.00653.
    >> Share

  66. AKAISHI T, Horii A, Ishii T
    Sequence Exchange Involving Dozens of Consecutive Bases with External Origin in SARS-Related Coronaviruses.
    J Virol. 2022 Jul 20:e0100222. doi: 10.1128/jvi.01002.
    >> Share


  67. KIM YE, Huh K, Park YJ, Peck KR, et al
    Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection.
    JAMA. 2022 Jul 22. pii: 2794753. doi: 10.1001/jama.2022.12992.
    >> Share

  68. WEBER E, Van Buren N, Cunningham T
    COVID-19 ARDS and Posttraumatic Stress Disorder in Family Members After ICU Discharge.
    JAMA. 2022;328:301-302.
    >> Share

  69. LIN HY, Chen MH, Liang CS
    COVID-19 ARDS and Posttraumatic Stress Disorder in Family Members After ICU Discharge.
    JAMA. 2022;328:301.
    >> Share

  70. KENIK J
    Remote Patient Monitoring During COVID-19.
    JAMA. 2022;328:302-303.
    >> Share

  71. AZOULAY E, Pochard F, Kentish-Barnes N
    COVID-19 ARDS and Posttraumatic Stress Disorder in Family Members After ICU Discharge-Reply.
    JAMA. 2022;328:302.
    >> Share

  72. PRONOVOST PJ, Cole MD, Hughes RM
    Remote Patient Monitoring During COVID-19-Reply.
    JAMA. 2022;328:303-304.
    >> Share

    Mix-and-Match COVID-19 Boosters After Inactivated Virus Vaccine.
    JAMA. 2022;328:234.
    >> Share


  74. LAWTON T, Alwan NA
    The UK COVID-19 Inquiry must examine the foundations of pandemic decision making.
    Lancet. 2022 Jul 18. pii: S0140-6736(22)01332.
    >> Share

  75. MESSACAR K, Baker RE, Park SW, Nguyen-Tran H, et al
    Preparing for uncertainty: endemic paediatric viral illnesses after COVID-19 pandemic disruption.
    Lancet. 2022 Jul 14. pii: S0140-6736(22)01277.
    >> Share

  76. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020.
    Lancet. 2022;400:185-235.
    >> Share

    Perilous two-tier COVID-19 global vaccine roll-out.
    Lancet. 2022 Jul 11. pii: S0140-6736(22)01284.
    >> Share

  78. WOLTER N, Jassat W, von Gottberg A, Cohen C, et al
    Clinical severity of omicron lineage BA.2 infection compared with BA.1 infection in South Africa.
    Lancet. 2022;400:93-96.
    >> Share

    Lancet Infect Dis

  79. MCMENAMIN ME, Nealon J, Lin Y, Wong JY, et al
    Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study.
    Lancet Infect Dis. 2022 Jul 15. pii: S1473-3099(22)00345.
    >> Share

  80. SUN F, Lin Y, Wang X, Gao Y, et al
    Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection.
    Lancet Infect Dis. 2022 Jul 14. pii: S1473-3099(22)00430.
    >> Share

    Life Sci

  81. ALI MA, El-Tahan RA, Kamel MA, Matar NA, et al
    The diabetogenic effects of chronic supplementation of vitamin C or E in rats: Interplay between liver and adipose tissues transcriptional machinery of lipid metabolism.
    Life Sci. 2022 Jul 18:120812. doi: 10.1016/j.lfs.2022.120812.
    >> Share

  82. MALEKINEJAD Z, Baghbanzadeh A, Nakhlband A, Baradaran B, et al
    Recent clinical findings on the role of kinase inhibitors in COVID-19 management.
    Life Sci. 2022 Jul 13:120809. doi: 10.1016/j.lfs.2022.120809.
    >> Share

    MMWR Morb Mortal Wkly Rep

  83. LINK-GELLES R, Levy ME, Gaglani M, Irving SA, et al
    Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:931-939.
    >> Share

  84. MERCED-MORALES A, Daly P, Abd Elal AI, Ajayi N, et al
    Influenza Activity and Composition of the 2022-23 Influenza Vaccine - United States, 2021-22 Season.
    MMWR Morb Mortal Wkly Rep. 2022;71:913-919.
    >> Share

  85. KONE A, Horter L, Thomas I, Byrkit R, et al
    Symptoms of Mental Health Conditions and Suicidal Ideation Among State, Tribal, Local, and Territorial Public Health Workers - United States, March 14-25, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:925-930.
    >> Share

  86. HARE BORK R, Robins M, Schaffer K, Leider JP, et al
    Workplace Perceptions and Experiences Related to COVID-19 Response Efforts Among Public Health Workers - Public Health Workforce Interests and Needs Survey, United States, September 2021-January 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:920-924.
    >> Share

  87. TRAUB AM, Medley A, Gross J, Sloan M, et al
    Pediatric HIV Case Identification Across 22 PEPFAR-Supported Countries During the COVID-19 Pandemic, October 2019-September 2020.
    MMWR Morb Mortal Wkly Rep. 2022;71:894-898.
    >> Share

  88. HAUSE AM, Baggs J, Marquez P, Abara WE, et al
    Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged >/=12 Years with Presumed Immunocompromise Status - United States, January 12, 2022-March 28, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:899-903.
    >> Share

    N Engl J Med

  89. TAN SHX, Cook AR, Heng D, Ong B, et al
    Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of Age.
    N Engl J Med. 2022 Jul 20. doi: 10.1056/NEJMoa2203209.
    >> Share

  90. RUBIN EJ, Baden LR, Jha A, Morrissey S, et al
    Audio Interview: A Look at the U.S. Government's Covid-19 Strategy.
    N Engl J Med. 2022;387:e11.
    >> Share

  91. MAIER HE, Balmaseda A, Saborio S, Ojeda S, et al
    Protection Associated with Previous SARS-CoV-2 Infection in Nicaragua.
    N Engl J Med. 2022 Jul 20. doi: 10.1056/NEJMc2203985.
    >> Share

  92. HAMMOND J, Bao W, Simon-Campos A
    Nirmatrelvir for Nonhospitalized Adults with Covid-19. Reply.
    N Engl J Med. 2022;387.
    >> Share

  93. MORRIS AM, Lee TC
    Nirmatrelvir for Nonhospitalized Adults with Covid-19.
    N Engl J Med. 2022;387.
    >> Share

  94. CHEN BS, Hung CH, Wei JC
    Nirmatrelvir for Nonhospitalized Adults with Covid-19.
    N Engl J Med. 2022;387.
    >> Share


    Prior Omicron infection protects against BA.4 and BA.5 variants.
    Nature. 2022 Jul 21. pii: 10.1038/d41586-022-01950.
    >> Share

  96. KEMP SA, Collier DA, Datir RP, Ferreira IATM, et al
    Author Correction: SARS-CoV-2 evolution during treatment of chronic infection.
    Nature. 2022 Jul 21. pii: 10.1038/s41586-022-05104.
    >> Share

  97. COLLIER DA, De Marco A, Ferreira IATM, Meng B, et al
    Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.
    Nature. 2022 Jul 21. pii: 10.1038/s41586-022-05103.
    >> Share

  98. COVID immunity, 3D nucleus - the week in infographics.
    Nature. 2022 Jul 19. pii: 10.1038/d41586-022-01989.
    >> Share

  99. SIDIK SM
    The hunt for drugs for mild COVID: scientists seek to treat those at lower risk.
    Nature. 2022 Jul 18. pii: 10.1038/d41586-022-01923.
    >> Share

    One coronavirus infection wards off another - but only if it's a similar variant.
    Nature. 2022 Jul 14. pii: 10.1038/d41586-022-01914.
    >> Share

  101. MAXMEN A
    Unseating big pharma: the radical plan for vaccine equity.
    Nature. 2022;607:226-233.
    >> Share

  102. Why a vaccine hub for low-income countries must succeed.
    Nature. 2022;607:211-212.
    >> Share

    Radiol Cardiothorac Imaging

  103. ANANTHAKRISHNAN L, Kay FU, Zeikus EA, Chu ES, et al
    What the Baby Formula and Medical Contrast Material Shortages Have in Common: Insights and Recommendations for Managing the Iodinated Contrast Media Shortage.
    Radiol Cardiothorac Imaging. 2022;4:e220101.
    >> Share


  104. LOW JS, Jerak J, Tortorici MA, McCallum M, et al
    ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies.
    Science. 2022 Jul 12:eabq2679. doi: 10.1126/science.abq2679.
    >> Share

  105. COHEN AA, van Doremalen N, Greaney AJ, Andersen H, et al
    Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models.
    Science. 2022 Jul 5:eabq0839. doi: 10.1126/science.abq0839.
    >> Share

    Nailing the nuance on COVID-19.
    Science. 2022;377:243.
    >> Share

  107. MITCHAM C, Nordmann A, Liu Y
    Zero-COVID Editorial lacks balance.
    Science. 2022;377:270-271.
    >> Share

  108. CHEN R, Guo X, Zhu A
    Vaccinate to combat COVID-19 in China.
    Science. 2022;377:271.
    >> Share

    Bad news for Paxlovid? Resistance may be coming.
    Science. 2022;377:138-139.
    >> Share

  110. BOWEN JE, Addetia A, Dang HV, Stewart C, et al
    Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines.
    Science. 2022 Jul 19:eabq0203. doi: 10.1126/science.abq0203.
    >> Share

  111. DACON C, Tucker C, Peng L, Lee CD, et al
    Broadly neutralizing antibodies target the coronavirus fusion peptide.
    Science. 2022 Jul 12:eabq3773. doi: 10.1126/science.abq3773.
    >> Share

    Travel Med Infect Dis

  112. LUNA N, Ramirez AL, Munoz M, Ballesteros N, et al
    Phylogenomic analysis of the monkeypox virus (MPXV) 2022 outbreak: Emergence of a novel viral lineage?
    Travel Med Infect Dis. 2022;49:102402.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016